nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—Hoarseness—Sorafenib—thyroid cancer	0.0279	0.0279	CcSEcCtD
Flunisolide—Laryngitis—Vandetanib—thyroid cancer	0.0252	0.0252	CcSEcCtD
Flunisolide—Glaucoma—Vandetanib—thyroid cancer	0.0242	0.0242	CcSEcCtD
Flunisolide—Cataract—Vandetanib—thyroid cancer	0.0191	0.0191	CcSEcCtD
Flunisolide—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Flunisolide—Rhinorrhoea—Sorafenib—thyroid cancer	0.0151	0.0151	CcSEcCtD
Flunisolide—Dysphonia—Sorafenib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Flunisolide—Gastroenteritis—Vandetanib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Flunisolide—Glossitis—Sorafenib—thyroid cancer	0.0133	0.0133	CcSEcCtD
Flunisolide—Nasopharyngitis—Vandetanib—thyroid cancer	0.0118	0.0118	CcSEcCtD
Flunisolide—Bronchospasm—Vandetanib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Flunisolide—Bronchitis—Vandetanib—thyroid cancer	0.011	0.011	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.0106	0.0106	CcSEcCtD
Flunisolide—Pneumonia—Vandetanib—thyroid cancer	0.0102	0.0102	CcSEcCtD
Flunisolide—Stomatitis—Vandetanib—thyroid cancer	0.00992	0.00992	CcSEcCtD
Flunisolide—Eczema—Sorafenib—thyroid cancer	0.00991	0.00991	CcSEcCtD
Flunisolide—Conjunctivitis—Vandetanib—thyroid cancer	0.00989	0.00989	CcSEcCtD
Flunisolide—Urinary tract infection—Vandetanib—thyroid cancer	0.00989	0.00989	CcSEcCtD
Flunisolide—Epistaxis—Vandetanib—thyroid cancer	0.0096	0.0096	CcSEcCtD
Flunisolide—Sinusitis—Vandetanib—thyroid cancer	0.00955	0.00955	CcSEcCtD
Flunisolide—Erythema multiforme—Vandetanib—thyroid cancer	0.00864	0.00864	CcSEcCtD
Flunisolide—Nasopharyngitis—Sorafenib—thyroid cancer	0.00797	0.00797	CcSEcCtD
Flunisolide—Malnutrition—Vandetanib—thyroid cancer	0.00795	0.00795	CcSEcCtD
Flunisolide—Dysgeusia—Vandetanib—thyroid cancer	0.00779	0.00779	CcSEcCtD
Flunisolide—Vision blurred—Vandetanib—thyroid cancer	0.0075	0.0075	CcSEcCtD
Flunisolide—Tremor—Vandetanib—thyroid cancer	0.00745	0.00745	CcSEcCtD
Flunisolide—Abdominal discomfort—Sorafenib—thyroid cancer	0.00738	0.00738	CcSEcCtD
Flunisolide—Oral candidiasis—Epirubicin—thyroid cancer	0.00714	0.00714	CcSEcCtD
Flunisolide—Loss of consciousness—Vandetanib—thyroid cancer	0.00699	0.00699	CcSEcCtD
Flunisolide—Cough—Vandetanib—thyroid cancer	0.00694	0.00694	CcSEcCtD
Flunisolide—Pneumonia—Sorafenib—thyroid cancer	0.00691	0.00691	CcSEcCtD
Flunisolide—Hypertension—Vandetanib—thyroid cancer	0.00687	0.00687	CcSEcCtD
Flunisolide—Chest pain—Vandetanib—thyroid cancer	0.00677	0.00677	CcSEcCtD
Flunisolide—Anxiety—Vandetanib—thyroid cancer	0.00675	0.00675	CcSEcCtD
Flunisolide—Hypokinesia—Epirubicin—thyroid cancer	0.00672	0.00672	CcSEcCtD
Flunisolide—Stomatitis—Sorafenib—thyroid cancer	0.00669	0.00669	CcSEcCtD
Flunisolide—Oral candidiasis—Doxorubicin—thyroid cancer	0.00661	0.00661	CcSEcCtD
Flunisolide—Oedema—Vandetanib—thyroid cancer	0.00649	0.00649	CcSEcCtD
Flunisolide—Epistaxis—Sorafenib—thyroid cancer	0.00648	0.00648	CcSEcCtD
Flunisolide—Infection—Vandetanib—thyroid cancer	0.00645	0.00645	CcSEcCtD
Flunisolide—Laryngitis—Epirubicin—thyroid cancer	0.00629	0.00629	CcSEcCtD
Flunisolide—Hypokinesia—Doxorubicin—thyroid cancer	0.00622	0.00622	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00591	0.00591	CcSEcCtD
Flunisolide—Insomnia—Vandetanib—thyroid cancer	0.00587	0.00587	CcSEcCtD
Flunisolide—Erythema multiforme—Sorafenib—thyroid cancer	0.00583	0.00583	CcSEcCtD
Flunisolide—Laryngitis—Doxorubicin—thyroid cancer	0.00582	0.00582	CcSEcCtD
Flunisolide—Dyspnoea—Vandetanib—thyroid cancer	0.00579	0.00579	CcSEcCtD
Flunisolide—Dyspepsia—Vandetanib—thyroid cancer	0.00571	0.00571	CcSEcCtD
Flunisolide—Decreased appetite—Vandetanib—thyroid cancer	0.00564	0.00564	CcSEcCtD
Flunisolide—Stinging—Epirubicin—thyroid cancer	0.0056	0.0056	CcSEcCtD
Flunisolide—Ageusia—Epirubicin—thyroid cancer	0.0056	0.0056	CcSEcCtD
Flunisolide—Fatigue—Vandetanib—thyroid cancer	0.0056	0.0056	CcSEcCtD
Flunisolide—Pain—Vandetanib—thyroid cancer	0.00555	0.00555	CcSEcCtD
Flunisolide—Constipation—Vandetanib—thyroid cancer	0.00555	0.00555	CcSEcCtD
Flunisolide—Dysphonia—Epirubicin—thyroid cancer	0.00551	0.00551	CcSEcCtD
Flunisolide—Malnutrition—Sorafenib—thyroid cancer	0.00537	0.00537	CcSEcCtD
Flunisolide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00531	0.00531	CcSEcCtD
Flunisolide—Dysgeusia—Sorafenib—thyroid cancer	0.00525	0.00525	CcSEcCtD
Flunisolide—Ageusia—Doxorubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Flunisolide—Stinging—Doxorubicin—thyroid cancer	0.00518	0.00518	CcSEcCtD
Flunisolide—Body temperature increased—Vandetanib—thyroid cancer	0.00513	0.00513	CcSEcCtD
Flunisolide—Abdominal pain—Vandetanib—thyroid cancer	0.00513	0.00513	CcSEcCtD
Flunisolide—Dysphonia—Doxorubicin—thyroid cancer	0.0051	0.0051	CcSEcCtD
Flunisolide—Cough increased—Epirubicin—thyroid cancer	0.00495	0.00495	CcSEcCtD
Flunisolide—Lacrimation increased—Epirubicin—thyroid cancer	0.00492	0.00492	CcSEcCtD
Flunisolide—Glossitis—Epirubicin—thyroid cancer	0.00492	0.00492	CcSEcCtD
Flunisolide—Syncope—Sorafenib—thyroid cancer	0.00481	0.00481	CcSEcCtD
Flunisolide—Loss of consciousness—Sorafenib—thyroid cancer	0.00472	0.00472	CcSEcCtD
Flunisolide—Cough—Sorafenib—thyroid cancer	0.00468	0.00468	CcSEcCtD
Flunisolide—Asthenia—Vandetanib—thyroid cancer	0.00466	0.00466	CcSEcCtD
Flunisolide—Hypertension—Sorafenib—thyroid cancer	0.00463	0.00463	CcSEcCtD
Flunisolide—Pruritus—Vandetanib—thyroid cancer	0.00459	0.00459	CcSEcCtD
Flunisolide—Neck pain—Epirubicin—thyroid cancer	0.00459	0.00459	CcSEcCtD
Flunisolide—Cough increased—Doxorubicin—thyroid cancer	0.00458	0.00458	CcSEcCtD
Flunisolide—Myalgia—Sorafenib—thyroid cancer	0.00457	0.00457	CcSEcCtD
Flunisolide—Glossitis—Doxorubicin—thyroid cancer	0.00455	0.00455	CcSEcCtD
Flunisolide—Lacrimation increased—Doxorubicin—thyroid cancer	0.00455	0.00455	CcSEcCtD
Flunisolide—Vaginal inflammation—Epirubicin—thyroid cancer	0.00454	0.00454	CcSEcCtD
Flunisolide—Diarrhoea—Vandetanib—thyroid cancer	0.00444	0.00444	CcSEcCtD
Flunisolide—Infection—Sorafenib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Flunisolide—Candida infection—Epirubicin—thyroid cancer	0.00433	0.00433	CcSEcCtD
Flunisolide—Shock—Sorafenib—thyroid cancer	0.00431	0.00431	CcSEcCtD
Flunisolide—Dizziness—Vandetanib—thyroid cancer	0.00429	0.00429	CcSEcCtD
Flunisolide—Vaginal infection—Epirubicin—thyroid cancer	0.00428	0.00428	CcSEcCtD
Flunisolide—Neck pain—Doxorubicin—thyroid cancer	0.00425	0.00425	CcSEcCtD
Flunisolide—Vaginal inflammation—Doxorubicin—thyroid cancer	0.0042	0.0042	CcSEcCtD
Flunisolide—Vomiting—Vandetanib—thyroid cancer	0.00413	0.00413	CcSEcCtD
Flunisolide—Rash—Vandetanib—thyroid cancer	0.00409	0.00409	CcSEcCtD
Flunisolide—Dermatitis—Vandetanib—thyroid cancer	0.00409	0.00409	CcSEcCtD
Flunisolide—Headache—Vandetanib—thyroid cancer	0.00407	0.00407	CcSEcCtD
Flunisolide—Candida infection—Doxorubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00399	0.00399	CcSEcCtD
Flunisolide—Vaginal infection—Doxorubicin—thyroid cancer	0.00396	0.00396	CcSEcCtD
Flunisolide—Dyspnoea—Sorafenib—thyroid cancer	0.0039	0.0039	CcSEcCtD
Flunisolide—Lymphadenopathy—Epirubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Flunisolide—Nausea—Vandetanib—thyroid cancer	0.00386	0.00386	CcSEcCtD
Flunisolide—Dyspepsia—Sorafenib—thyroid cancer	0.00385	0.00385	CcSEcCtD
Flunisolide—Decreased appetite—Sorafenib—thyroid cancer	0.00381	0.00381	CcSEcCtD
Flunisolide—Fatigue—Sorafenib—thyroid cancer	0.00378	0.00378	CcSEcCtD
Flunisolide—Pain—Sorafenib—thyroid cancer	0.00374	0.00374	CcSEcCtD
Flunisolide—Constipation—Sorafenib—thyroid cancer	0.00374	0.00374	CcSEcCtD
Flunisolide—Eczema—Epirubicin—thyroid cancer	0.00366	0.00366	CcSEcCtD
Flunisolide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00358	0.00358	CcSEcCtD
Flunisolide—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00357	0.00357	CcSEcCtD
Flunisolide—Increased appetite—Epirubicin—thyroid cancer	0.0035	0.0035	CcSEcCtD
Flunisolide—Urticaria—Sorafenib—thyroid cancer	0.00348	0.00348	CcSEcCtD
Flunisolide—Abdominal pain—Sorafenib—thyroid cancer	0.00346	0.00346	CcSEcCtD
Flunisolide—Body temperature increased—Sorafenib—thyroid cancer	0.00346	0.00346	CcSEcCtD
Flunisolide—Eczema—Doxorubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Flunisolide—Increased appetite—Doxorubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Flunisolide—Migraine—Epirubicin—thyroid cancer	0.00324	0.00324	CcSEcCtD
Flunisolide—Hypersensitivity—Sorafenib—thyroid cancer	0.00323	0.00323	CcSEcCtD
Flunisolide—Asthenia—Sorafenib—thyroid cancer	0.00314	0.00314	CcSEcCtD
Flunisolide—Pruritus—Sorafenib—thyroid cancer	0.0031	0.0031	CcSEcCtD
Flunisolide—Migraine—Doxorubicin—thyroid cancer	0.003	0.003	CcSEcCtD
Flunisolide—Diarrhoea—Sorafenib—thyroid cancer	0.003	0.003	CcSEcCtD
Flunisolide—Nasopharyngitis—Epirubicin—thyroid cancer	0.00294	0.00294	CcSEcCtD
Flunisolide—Dizziness—Sorafenib—thyroid cancer	0.0029	0.0029	CcSEcCtD
Flunisolide—Abdominal distension—Epirubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Flunisolide—Vomiting—Sorafenib—thyroid cancer	0.00278	0.00278	CcSEcCtD
Flunisolide—Rash—Sorafenib—thyroid cancer	0.00276	0.00276	CcSEcCtD
Flunisolide—Dermatitis—Sorafenib—thyroid cancer	0.00276	0.00276	CcSEcCtD
Flunisolide—Headache—Sorafenib—thyroid cancer	0.00274	0.00274	CcSEcCtD
Flunisolide—Bronchitis—Epirubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Flunisolide—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Flunisolide—Abdominal distension—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Flunisolide—Nausea—Sorafenib—thyroid cancer	0.0026	0.0026	CcSEcCtD
Flunisolide—Weight increased—Epirubicin—thyroid cancer	0.00259	0.00259	CcSEcCtD
Flunisolide—Pneumonia—Epirubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Flunisolide—Bronchitis—Doxorubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Flunisolide—Stomatitis—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Flunisolide—Urinary tract infection—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Flunisolide—Conjunctivitis—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Flunisolide—Sweating—Epirubicin—thyroid cancer	0.00243	0.00243	CcSEcCtD
Flunisolide—Weight increased—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Flunisolide—Epistaxis—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Flunisolide—Sinusitis—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Flunisolide—Stomatitis—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Flunisolide—Rhinitis—Epirubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Flunisolide—Hypoaesthesia—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Flunisolide—Pharyngitis—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Flunisolide—Sweating—Doxorubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Flunisolide—Oedema peripheral—Epirubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Flunisolide—Epistaxis—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Flunisolide—Sinusitis—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Flunisolide—Erythema multiforme—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Flunisolide—Oedema peripheral—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Flunisolide—Chills—Epirubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Flunisolide—Erythema multiforme—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Flunisolide—Malnutrition—Epirubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Flunisolide—Dysgeusia—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Flunisolide—Back pain—Epirubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Flunisolide—Chills—Doxorubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Flunisolide—Vision blurred—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Flunisolide—Ill-defined disorder—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Flunisolide—Agitation—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Flunisolide—Malaise—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Flunisolide—Vertigo—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Flunisolide—Syncope—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Flunisolide—Palpitations—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Flunisolide—Loss of consciousness—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Flunisolide—Cough—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Flunisolide—Hypertension—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Flunisolide—Chest pain—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Flunisolide—Myalgia—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Flunisolide—Anxiety—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Flunisolide—Discomfort—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Flunisolide—Malaise—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Flunisolide—Syncope—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Flunisolide—Palpitations—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Flunisolide—Oedema—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Flunisolide—Loss of consciousness—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Flunisolide—Infection—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Flunisolide—Cough—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Flunisolide—Shock—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Flunisolide—Tachycardia—Epirubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Flunisolide—Hyperhidrosis—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Flunisolide—Discomfort—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Flunisolide—Infection—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Flunisolide—Shock—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Flunisolide—Insomnia—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Flunisolide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Flunisolide—Dyspnoea—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Flunisolide—Dyspepsia—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Flunisolide—Decreased appetite—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Flunisolide—Fatigue—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Flunisolide—Pain—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Flunisolide—Constipation—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Flunisolide—Dyspnoea—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Flunisolide—Feeling abnormal—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Flunisolide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Flunisolide—Dyspepsia—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Flunisolide—Decreased appetite—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Flunisolide—Fatigue—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Flunisolide—Urticaria—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Flunisolide—Pain—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Flunisolide—Constipation—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Flunisolide—Abdominal pain—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Flunisolide—Body temperature increased—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Flunisolide—Feeling abnormal—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Flunisolide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Flunisolide—Hypersensitivity—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Flunisolide—Urticaria—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Flunisolide—Abdominal pain—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Flunisolide—Asthenia—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Flunisolide—Pruritus—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Flunisolide—Diarrhoea—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Flunisolide—Asthenia—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Flunisolide—Dizziness—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Flunisolide—Vomiting—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Flunisolide—Rash—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Flunisolide—Dermatitis—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Flunisolide—Headache—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Flunisolide—Dizziness—Doxorubicin—thyroid cancer	0.00099	0.00099	CcSEcCtD
Flunisolide—Nausea—Epirubicin—thyroid cancer	0.000961	0.000961	CcSEcCtD
Flunisolide—Vomiting—Doxorubicin—thyroid cancer	0.000952	0.000952	CcSEcCtD
Flunisolide—Rash—Doxorubicin—thyroid cancer	0.000944	0.000944	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—thyroid cancer	0.000943	0.000943	CcSEcCtD
Flunisolide—Headache—Doxorubicin—thyroid cancer	0.000938	0.000938	CcSEcCtD
Flunisolide—Nausea—Doxorubicin—thyroid cancer	0.000889	0.000889	CcSEcCtD
